[
  {
    "ts": null,
    "headline": "[Latest] Global Advanced Wound Closure Market Size/Share Worth USD 32.54 Billion by 2035 at a 6.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Advanced Wound Closure Market size & share revenue was valued at approximately USD 18.47 Billion in 2025 and is expected to reach USD 19.68 Billion in 2026 and is expected to reach around USD 32.54 Billion by 2035, at a CAGR of 6.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Johnson & Johnson (Ethi",
    "url": "https://finnhub.io/api/news?id=3433ac30132a840866d60fcffaaa9780606709be3b861f6aa31bb1c98ce4c140",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770060600,
      "headline": "[Latest] Global Advanced Wound Closure Market Size/Share Worth USD 32.54 Billion by 2035 at a 6.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 138335067,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Advanced Wound Closure Market size & share revenue was valued at approximately USD 18.47 Billion in 2025 and is expected to reach USD 19.68 Billion in 2026 and is expected to reach around USD 32.54 Billion by 2035, at a CAGR of 6.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Johnson & Johnson (Ethi",
      "url": "https://finnhub.io/api/news?id=3433ac30132a840866d60fcffaaa9780606709be3b861f6aa31bb1c98ce4c140"
    }
  },
  {
    "ts": null,
    "headline": "Are Wall Street Analysts Predicting Medtronic Stock Will Climb or Sink?",
    "summary": "Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=d2f9310b63a78134c65ef1b2f26e6e9f3c6269236ac3e12e095cfd13c4fc0cae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770048493,
      "headline": "Are Wall Street Analysts Predicting Medtronic Stock Will Climb or Sink?",
      "id": 138335141,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=d2f9310b63a78134c65ef1b2f26e6e9f3c6269236ac3e12e095cfd13c4fc0cae"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances",
    "summary": "Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and insulin‑requiring type 2 diabetes. These milestones include Medicare access for the MiniMed™ 780G system paired with the Instinct sensor, made by Abbott, FDA clearance for the system's use with ultra rapid‑acting insulins, and clearance of the MiniMed™ 780G system for use with the Instinct sensor for insul",
    "url": "https://finnhub.io/api/news?id=01ab13153828e423462768559d833d7cbb1fada717230566040e60ecadfbed8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770041820,
      "headline": "Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances",
      "id": 138332495,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and insulin‑requiring type 2 diabetes. These milestones include Medicare access for the MiniMed™ 780G system paired with the Instinct sensor, made by Abbott, FDA clearance for the system's use with ultra rapid‑acting insulins, and clearance of the MiniMed™ 780G system for use with the Instinct sensor for insul",
      "url": "https://finnhub.io/api/news?id=01ab13153828e423462768559d833d7cbb1fada717230566040e60ecadfbed8a"
    }
  }
]